A couple of weeks ago we were starting an in depth clinical look at Metabolomics. In part one we started getting into the definitions of the science and the effects this has on insulin resistance and and diabetes. Part two added more information, and now in part three we start to look at …
Read More »Monthly Archives: October 2017
Osama Hamdy Part 5, The Future of Transcontinental Endocrinology
In part 5, the conclusion of this Exclusive Interview, Dr. Osama Hamdy talks with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas about the coming ease of managing diabetes consistently no matter which country a person with diabetes lives in or visits.
Read More »Albuminuria: A Lot More Than Just a Little Protein in the Urine Part 11
In this week's Homerun Slides, liraglutide's effects on and action in diabetes, and therapeutic ways to treat chronic kidney disease in people with type 2.
Read More »International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #97: Metabolomics: Applications in Type 2 Diabetes Mellitus and Insulin Resistance Part 3
Altered metabolites and their potential origins in type 2 diabetes and insulin resistance: In recent years, a large number of cross-sectional and prospective studies have revealed specific metabolites and pathways that are altered by, or predictive of, T2DM and insulin resistance.
Read More »Osama Hamdy Full Interview
In this Exclusive Interview, Dr. Osama Hamdy talks with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas about the importance of understanding and working with various cultural traditions in order to effectively manage diabetes anywhere in the world.
Read More »Oct. 28, 2017
The use of GLP-1 agonists just got easier. For the past couple of years, if your patient’s formulary paid for Trulicity, they had an easy time administering their dose. Adherence was improved because no mixing was necessary and you didn’t have to stare at the needle. Now Bydureon joins the …
Read More »Risk Of Mortality In Patients with Type 2 and Prior CV Event
New study finds that adults with type 2 diabetes and atherosclerotic cardiovascular disease have increased risk of mortality with a prior nonfatal cardiovascular (CV) event.
Read More »Pre-Pregnancy Vitamin D Intake Reduces Gestational Diabetes Risk
Large cohort suggests supplement increase beneficial in women of reproductive age.
Read More »Safety And Efficacy Of New Long-Acting Exenatide Formulation
Once-weekly exenatide formulation can provide as much benefit as the traditional twice-daily dosing.
Read More »Long-Term Benefits of Linoleic Acid In Type 2 Diabetes
High linoleic acid level could reduce type 2 risk by 43 percent, new study found.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.